Faculty Opinions recommendation of Generation 2.5 antisense oligonucleotides targeting the androgen receptor and its splice variants suppress enzalutamide-resistant prostate cancer cell growth.

2015 ◽  
Author(s):  
Charlotte Bevan ◽  
Greg Brooke
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Cell Growth ◽  
Cancer Cell ◽  
Antisense Oligonucleotides ◽  
Prostate Cancer Cell ◽  
Splice Variants ◽  
Cancer Cell Growth

321 ANTISENSE INHIBITOR TARGETING FULL LENGTH ANDROGEN RECEPTOR AND ITS SPLICE VARIANTS SUPPRESSES MDV3100 RESISTANT PROSTATE CANCER CELL GROWTH

2013 ◽  
Vol 189 (4S) ◽  
Author(s):  
Yoshiaki Yamamoto ◽  
Eliana Beraldi ◽  
Hidetoshi Kuruma ◽  
Hiroaki Matsumoto ◽  
Yohann Loriot ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Cell Growth ◽  
Cancer Cell ◽  
Prostate Cancer Cell ◽  
Splice Variants ◽  
Full Length ◽  
Cancer Cell Growth

scholarly journals Inhibition of prostate cancer cell growth by second-site androgen receptor antagonists

2009 ◽  
Vol 106 (29) ◽  
pp. 12178-12183 ◽  
Author(s):  
J. D. Joseph ◽  
B. M. Wittmann ◽  
M. A. Dwyer ◽  
H. Cui ◽  
D. A. Dye ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Receptor ◽  
Cell Growth ◽  
Cancer Cell ◽  
Prostate Cancer Cell ◽  
Receptor Antagonists ◽  
Cancer Cell Growth ◽  
Androgen Receptor Antagonists

Inhibition of PC-3 Prostate Cancer Cell Growth In Vitro Using Both Antisense Oligonucleotides and Taxol

2003 ◽  
Vol 20 (1) ◽  
pp. 29-36 ◽  
Author(s):  
Marvin Rubenstein ◽  
Leonid Slobodskoy ◽  
Yelena Mirochnik ◽  
Patrick Guinan
Keyword(s):  
Prostate Cancer ◽  
Cell Growth ◽  
Cancer Cell ◽  
Antisense Oligonucleotides ◽  
Prostate Cancer Cell ◽  
Cancer Cell Growth
Sign in / Sign up

Export Citation Format

Share Document